Finally, our data confirmed previously published results which showed that there is no association between ADH upgrade and the presence of other B3 lesions [12, 29–32]; it seems that, when ADH is present, its own risk of upgrade overwhelms the risk associated with other B3 lesions such as FEA, LN, papilloma or RS. This evidence concerns the gene AVP and papilloma.